Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose:: Not yet!

被引：52
|
作者：
Guller, U
Nitzsche, EU
Schirp, U
Viehl, CT
Torhorst, J
Moch, H
Langer, I
Marti, WR
Oertli, D
Harder, F
Zuber, M [1 ]
机构：
[1] Kantonsspital Olten, Dept Surg, CH-4600 Olten, Switzerland
[2] Univ Basel, Dept Surg, Basel, Switzerland
[3] Univ Basel, Dept Radiol, Inst Nucl Med, Basel, Switzerland
[4] Univ Basel, Inst Pathol, Basel, Switzerland
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 71卷 / 02期
关键词：
F-18-fluoro-2-deoxy-D-glucose; positron emission tomography; invasive breast cancer; micrometastases; sentinel lymph node;
D O I：
10.1023/A:1013828710301
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We prospectively evaluated 31 patients with invasive breast cancer. Preoperative positron emission tomography (PET) with F-18-fluoro-2-deoxy-D-glucose (F-18-FDG) for detection of axillary lymph node metastases was compared with the histopathologic status of the sentinel lymph node (SLN). Sensitivity of PET imaging was 43%, specificity and negative predictive value were 94 and 67%, respectively. The smallest metastasis detected by PET measured 3 mm in diameter. The results of this study suggest that detection of small axillary lymph node metastases is limited by the currently achievable spatial resolution of PET imaging. Selective axillary surgery in breast cancer patients based on F-18-FDG PET is yet not possible.
引用
收藏
页码：171 / 173
页数：3
相关论文
共 50 条
  • [41] 2-Deoxy-2-[18F]fluoro-d-glucose-Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Diagnosis of Patients with Recurrent Papillary Thyroid Cancer
    Andrei Iagaru
    Rinat Masamed
    Peter A. Singer
    Peter S. Conti
    Molecular Imaging and Biology, 2006, 8 : 309 - 314
  • [42] Value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma
    Cheng, Gang
    Servaes, Sabah
    Zhuang, Hongming
    LEUKEMIA & LYMPHOMA, 2013, 54 (04) : 737 - 742
  • [43] Clinical-diagnostic relevance of breast "incidentaloma" detected during 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography: Correlation with radiological imaging and histopathology
    Panareo, Stefano
    Urso, Luca
    Nieri, Alberto
    Caracciolo, Matteo
    Valpiani, Giorgia
    Torricelli, Pietro
    Frassoldati, Antonio
    Cittanti, Corrado
    Rollo, Marco
    Bartolomei, Mirco
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2021, 36 (04): : 385 - 390
  • [44] DIAGNOSIS OF PANCREATIC-CANCER BY 2[F-18]-FLUORO-2-DEOXY-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY
    FRIESS, H
    LANGHANS, J
    EBERT, M
    BEGER, HG
    STOLLFUSS, J
    RESKE, SN
    BUCHLER, MW
    GUT, 1995, 36 (05) : 771 - 777
  • [45] 18F-fluoro-2-deoxy-D-glucose retention index as a prognostic parameter in patients with pancreatic cancer
    Xi, Yun
    Guo, Rui
    Hu, Jiajia
    Zhang, Min
    Zhang, Xiangming
    Li, Biao
    NUCLEAR MEDICINE COMMUNICATIONS, 2014, 35 (11) : 1112 - 1118
  • [46] A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma
    Isasi, CR
    Lu, P
    Blaufox, MD
    CANCER, 2005, 104 (05) : 1066 - 1074
  • [47] 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography of head and neck in patients with nasopharyngeal carcinomas
    Changlai, SP
    Kao, CH
    Chieng, PU
    ONCOLOGY REPORTS, 1997, 4 (06) : 1331 - 1334
  • [48] Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study
    Johansen, J
    Eigtved, A
    Buchwald, C
    Theilgaard, SA
    Hansen, HS
    LARYNGOSCOPE, 2002, 112 (11): : 2009 - 2014
  • [49] Fluoro-2-deoxy-D-glucose positron emission tomography in lung cancer
    Strauss, H. William
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (05) : S48 - S48
  • [50] Positron emission tomography agent 2-deoxy-2-[18F] fluoro-D-glucose has a therapeutic potential in breast cancer
    Moadel, RM
    Nguyen, AV
    Lin, EY
    Lu, P
    Mani, J
    Blaufox, MD
    Pollard, JW
    Dadachova, E
    BREAST CANCER RESEARCH, 2003, 5 (06) : R199 - R205
12345